ACC |
Adrenocortical Carcinoma |
AD |
Adenocarcinoma |
AML |
Acute Myeloid Leukemia |
BLC |
Bladder Urothelial Carcinoma |
BLGG |
Brain Lower Grade Glioma |
BRCA |
Breast Invasive Carcinoma |
CC |
Cervical Cancer |
DFS |
Disease Free Survival |
DLBL |
Diffuse Large B-cell Lymphoma |
FFPE |
Formalin-Fixed Paraffin-Embedded |
GBM |
Glioblastoma Multiforme |
H&N |
Head and Neck |
HCC |
Hepatocellular Carcinoma |
HSP |
Heat Shock Protein |
IHC |
Immunohistochemistry |
KICH |
Kidney Chromophobe |
KIRP |
Kidney Renal Papillary Cell Carcinoma |
mAb |
Monoclonal Antibody |
NSCLC |
Non-Small Cell Lung Carcinoma |
OS |
Overall Survival |
OV |
Ovarian Serous Cystadenocarcinoma |
pAb |
Polyclonal Antibody |
PCPG |
Pheochromocytoma and Paraganglioma |
PRECOG |
PREdiction of Clinical Outcomes from Genomic Profiles |
RFS |
Relapse Free Survival |
SARC |
Sarcoma |
SCC |
Squamous Cell Carcinoma |
SKCM |
Skin Cutaneous Melanoma |
TCGA |
The Cancer Genome Atlas |
THCA |
Thyroid carcinoma |
UCEC |
Uterine Corpus Endometrial Carcinoma |
UCS |
Uterine Carcinosarcoma |